Get informed when a big investor buys or sells
+ FollowOvervalued by 177.5% based on the discounted cash flow analysis.
Loading insider trades…
Loading congress trades…
| Market cap | $64.40 Million |
|---|---|
| Enterprise Value | - |
| Earnings per Share | $-0.07 |
| Beta | 0.8 |
| Outstanding Shares | 247,687,437 |
| P/E Ratio | -2.41 |
|---|---|
| PEG | 3.04 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Vext Science, Inc., through its various subsidiaries, operates as a comprehensive agricultural technology, services, and property management company within the United States cannabis sector. Its operations span the entire product lifecyc...